Melbourne (Australia) – 3rd December 2018. Telix Pharmaceuticals Limited is pleased to provide investors an audio link to the Investor Conference Call hosted by the Company and led by Managing Director and Group CEO, Dr Christian Behrenbruch, on Friday 30 November 2018. For full details click here.